Skip to content ↓

The Future of Life Sciences is Here

SHYFT Analytics and Medidata have joined forces, bringing together the leading platform for clinical development with the leading platform for commercial and real-world data analytics.

Introducing the Intelligent Platform for Life Sciences

Accelerating value

Demonstrate efficacy and safety, obtain regulatory approval and achieve peak revenue faster

Minimizing risk

De-risk the planning and execution of clinical development and commercialization strategies

Optimizing outcomes

Provide the best possible outcomes for patients, providers and payers with increasingly precise therapies

Close the loop on Clinical and Commercial Insights

SHYFT Analytics

World’s leading platform for commercial and real-world data analytics, providing insights on 45B patient records and 2M providers. Transform massive amounts of complex healthcare data into on-demand clinical and commercial insight.

Learn More

Medidata

World's leading platform in clinical development, helping over 1 million life science professionals to power over 14,000 studies for over 4M patients. Reinvent clinical development with a unified platform powered by pioneering analytics.

Learn More

Press Release

SHYFT Agrees to Acquisition by Medidata to Define the Future of Life Sciences

Medidata (NASDAQ: MDSO) today announced that it has entered into a definitive agreement to acquire SHYFT Analytics, bringing the leading platform for clinical development together with the leading platform for commercial and real-world data analytics.

Learn More